Home
Science
Facilities
About Us
Resources
Synthetic Biology Department

Contacts

Jay D. Keasling, Ph.D.
Director, Berkeley Center for Synthetic Biology
Department Head, Synthetic Biology
jdkeasling@lbl.gov

Kristin Balder-Froid
Division Deputy, Physical Biosciences Division
Planning and Strategic Development
khbalder-froid@lbl.gov

pbdwebmaster@lbl.gov

Mamala tree
Engineering environmentally friendly pathways
Remediating dangerous environmental contaminants
Converting plentiful, renewable resources into energy

Design Labs:
  Metabolic pathways
  Genetic circuits
  Bio-nanostructures
  Enzymes
  Molecular motors
  Biomembranes

Aims

Design Team

Background

Contacts

Intranet

Custom microbes featured in NY Times

Microbial factories make MIT Top Ten Technologies list

Gates Foundation awards $42.6M to synthetic biology effort


Jay Keasling, Samoa partner against AIDS in landmark agreement


The University of California, Berkeley, has signed an agreement with the Samoan government to isolate from an indigenous tree the gene for a promising anti-AIDS drug and to share any royalties from sale of a gene-derived drug with the people of Samoa. The agreement, announced September 30 in Apia, the capital of Samoa, supports Samoa's assertion of national sovereignty over the gene sequence of Prostratin, a drug extracted from the bark of the mamala tree (Homalanthus nutans). The drug currently is being studied by scientists around the world because of its potential to force the AIDS virus out of hibernation in the body's immune cells and into the line of fire of anti-AIDS drugs now in use. full story -->
Home | Science | Facilities | About Us | Employee Resources
Berkeley Lab | A-Z Index | Last updated August 19, 2005 | Phone Book | Feedback
DOE Office of Science
U.S. Department of Energy
Lawrence Berkeley National Laboratory